| Attributes and predictors of long COVID CH Sudre, B Murray, T Varsavsky, MS Graham, RS Penfold, RC Bowyer, ... Nature medicine 27 (4), 626-631, 2021 | 2408 | 2021 |
| Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study C Menni, K Klaser, A May, L Polidori, J Capdevila, P Louca, CH Sudre, ... The Lancet Infectious Diseases 21 (7), 939-949, 2021 | 1058 | 2021 |
| Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study M Antonelli, RS Penfold, J Merino, CH Sudre, E Molteni, S Berry, ... The Lancet Infectious Diseases 22 (1), 43-55, 2022 | 819 | 2022 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 339 | 2021 |
| COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study C Menni, A May, L Polidori, P Louca, J Wolf, J Capdevila, C Hu, ... The Lancet Infectious Diseases 22 (7), 1002-1010, 2022 | 252 | 2022 |
| Attributes and predictors of long-covid: analysis of covid cases and their symptoms collected by the covid symptoms study app (preprint) CH Sudre, B Murray, T Varsavsky, MS Graham, RS Penfold, RCE Bowyer, ... | 101 | 2020 |
| Gender differences in participation and reward on Stack Overflow A May, J Wachs, A Hannák Empirical Software Engineering 24, 1997-2019, 2019 | 98 | 2019 |
| Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app K Klaser, EJ Thompson, LH Nguyen, CH Sudre, M Antonelli, B Murray, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (12), 1254-1258, 2021 | 79 | 2021 |
| Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant E Molteni, CH Sudre, LDS Canas, SS Bhopal, RC Hughes, L Chen, ... Children 9 (5), 652, 2022 | 63 | 2022 |
| COVID-19 due to the B. 1.617. 2 (Delta) variant compared to B. 1.1. 7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study K Kläser, E Molteni, M Graham, LS Canas, MF Österdahl, M Antonelli, ... Scientific reports 12 (1), 10904, 2022 | 50 | 2022 |
| Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort M Antonelli, J Capdevila, A Chaudhari, J Granerod, LS Canas, ... Journal of Infection 82 (3), 384-390, 2021 | 35 | 2021 |
| App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden B Kennedy, H Fitipaldi, U Hammar, M Maziarz, N Tsereteli, N Oskolkov, ... Nature communications 13 (1), 2110, 2022 | 26 | 2022 |
| The effect of SARS-CoV-2 variant B. 1.1. 7 on symptomatology, re-infection and transmissibility MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... MedRxiv 10 (2021.01), 28.21250680, 2021 | 26 | 2021 |
| Author Correction: Attributes and predictors of long COVID CH Sudre, B Murray, T Varsavsky, MS Graham, RS Penfold, RC Bowyer, ... Nature Medicine 27 (6), 1116-1116, 2021 | 22 | 2021 |
| Knowledge barriers in the symptomatic-COVID-19 testing programme in the UK: an observational study MS Graham, A May, T Varsavsky, CH Sudre, B Murray, K Kläser, ... MedRxiv, 2021.03. 16.21253719, 2021 | 17 | 2021 |
| Knowledge barriers in a national symptomatic-COVID-19 testing programme MS Graham, A May, T Varsavsky, CH Sudre, B Murray, K Kläser, ... PLOS global public health 2 (1), e0000028, 2022 | 11 | 2022 |
| Disentangling post-vaccination symptoms from early COVID-19 LS Canas, MF Österdahl, J Deng, C Hu, S Selvachandran, L Polidori, ... EClinicalMedicine 42, 2021 | 10 | 2021 |
| Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study M Antonelli, RS Penfold, J Merino, CH Sudre, E Molteni, S Berry, ... medRxiv, 2021.05. 24.21257738, 2021 | 8 | 2021 |
| A comparison of SARS-CoV-2 symptom prevalence, duration, and risk of hospitalisation among vaccinated individuals from the ZOE COVID Study during Omicron versus Delta variant … C Menni, S Ourselin, A Hammers, E Molteni, M Antonelli, C Sudre The Lancet, 2022 | 4 | 2022 |
| Identification of optimal symptom combinations to trigger diagnostic work-up of suspected COVID-19 cases: analysis from a community-based, prospective, observational cohort M Antonelli, J Capdevila, A Chaudhari, J Granerod, LS Canas, ... medRxiv, 2020.11. 23.20237313, 2020 | 4 | 2020 |
